Skip to content

13F-HR filed by DAFNA Capital Management LLC

DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 74 holding rows worth $336,078,000.

Accession
0001389933-21-000004
Filed
2021-02-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A holdings report, 74 entries on the cover page, a total value of $336,078,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $336,078,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
STEREOTAXIS INC85916J409COMMON STOCK13,680,554$69,634,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM334,360$30,403,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM206,911$23,205,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM181,306$15,685,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM587,756$12,948,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM92,208$8,838,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR80,375$7,956,000thousands by filing date
DEXCOM INC COM252131107Stock21,138$7,815,000thousands by filing date
ATRICURE INC04963C209COM133,229$7,417,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH47,400$7,181,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM82,100$7,037,000thousands by filing date
CARDIOVASCULAR SYSTEMS INC141619106COMMON STOCK151,200$6,617,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW76,815$5,902,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock346,535$5,330,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO1,237,400$5,197,000thousands by filing date
AFFIMED N VN01045108COM874,357$5,089,000thousands by filing date
NEURONETICS INC64131A105COM443,717$4,930,000thousands by filing date
IDEAYA BIOSCIENCES INC COM45166A102Stock331,661$4,643,000thousands by filing date
TRANSLATE BIO INC.89374L104Common Stock225,393$4,154,000thousands by filing date
ACCURAY INC DEL004397105COM974,400$4,063,000thousands by filing date
CARA THERAPEUTICS INC140755109COM261,442$3,956,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM288,440$3,897,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR23,237$3,875,000thousands by filing date
APPLIED GENETIC TECHNOL CORP03820J100COM903,429$3,695,000thousands by filing date
RADIUS HEALTH INC750469AA6NOTE4,000,000$3,586,000thousands by filing dateprincipal
LUMINEX CORP55027E102COMMON STOCK154,091$3,563,000thousands by filing date
FILANA THERAPEUTICS INC14817C107CMN450,000$3,069,000thousands by filing date
CONSTELLATION PHARMACEUTICALS INC.210373106Common Stock100,594$2,897,000thousands by filing date
HOOKIPA PHARMA INC43906K100COM250,000$2,773,000thousands by filing date
KINNATE BIOPHARMA INC49705R105COM68,121$2,710,000thousands by filing date
VENUS CONCEPT INC92332W105COM1,500,000$2,595,000thousands by filing date
89BIO INC282559103COM105,478$2,570,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM455,900$2,567,000thousands by filing date
OTONOMY INC68906L105COM389,592$2,521,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM43,916$2,512,000thousands by filing date
MEREO BIOPHARMA GROUP PLC589492107CMN668,148$2,392,000thousands by filing date
MORPHIC HLDG INC61775R105COM61,467$2,062,000thousands by filing date
KADMON HLDGS INC48283N106COM470,361$1,952,000thousands by filing date
ALECTOR INC014442107COMMON STOCK127,500$1,929,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM85,000$1,845,000thousands by filing date
MEI PHARMA INC55279B202COM NEW691,000$1,824,000thousands by filing date
PREVAIL THERAPEUTICS INC74140Y101COM75,000$1,730,000thousands by filing date
NATUS MEDICAL INC639050103COM85,575$1,715,000thousands by filing date
LIQUIDIA CORPORATION COM NEW53635D202Stock575,000$1,696,000thousands by filing date
KARUNA THERAPEUTICS INC48576A100COM16,668$1,693,000thousands by filing date
FS DEV CORP303020101COM CL A150,000$1,650,000thousands by filing date
SCYNEXIS INC811292200COM NEW200,000$1,530,000thousands by filing date
Johnson & Johnson478160104COM9,400$1,479,000thousands by filing date
ALPINE IMMUNE SCIENCES INC02083G100COM113,202$1,426,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM85,119$1,414,000thousands by filing date
COMPUGEN LTDM25722105ORD115,202$1,395,000thousands by filing date
AERIE PHARMACEUTICALS INC00771VAB4NOTE 1.500%10/01,500,000$1,376,000thousands by filing dateprincipal
Mersana Therapeutics Inc59045L106Common Stock49,263$1,311,000thousands by filing date
BLUEBIRD BIO INC09609G100COM30,273$1,310,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM49,600$1,288,000thousands by filing date
VERONA PHARMA PLC925050106SPONSORED ADS161,507$1,131,000thousands by filing date
ADICET BIO INC007002108COM77,577$1,090,000thousands by filing date
PHASEBIO PHARMACEUTICALS INC717224109COM320,542$1,077,000thousands by filing date
LARIMAR THERAPEUTICS INC517125100COM48,428$1,037,000thousands by filing date
REVOLUTION MEDICINES INC COM76155X100Stock22,500$891,000thousands by filing date
PANDION THERAPEUTICS INC698340106COM58,222$865,000thousands by filing date
MASIMO CORP COM574795100Stock3,000$805,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock6,600$734,000thousands by filing date
NEXTCURE INC65343E108COM65,000$709,000thousands by filing date
INOGEN INC45780L104COM15,000$670,000thousands by filing date
ATHIRA PHARMA INC04746L104COM16,531$566,000thousands by filing date
GENFIT S A372279109ADS114,341$549,000thousands by filing date
IVERIC BIO INC46583P102COM68,951$476,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW22,000$393,000thousands by filing date
BIOTELEMETRY INC090672106COM5,200$375,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock9,000$294,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM10,000$222,000thousands by filing date
SCPHARMACEUTICALS INC810648105COM38,891$206,000thousands by filing date
LINEAGE CELL THERAPEUTICS IN53566P109COMMON STOCK80,000$141,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001389933-21-000004this filing2021-02-16acceptance time not in the bulk data set